Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Giralt

Showing results (71-80 of 176) with videos related to

Pageof 18
Sort By:
Leukemia|August 26, 2016
Long-term event-free and overall survival after risk-adapted melphalan and SCT for systemic light chain amyloidosisH Landau, M Smith, C Landry, et al.
Bone Marrow Transplantation|September 1, 1994
A phase I-II study of high-dose thiotepa, busulfan and cyclophosphamide as a preparative regimen for allogeneic marrow transplantationD Przepiorka, C Ippoliti, S Giralt, et al.
Bone Marrow Transplantation|April 1, 1994
Ganciclovir three times per week is not adequate to prevent cytomegalovirus reactivation after T cell-depleted marrow transplantationD Przepiorka, C Ippoliti, A Panina, et al.
Bone Marrow Transplantation|May 1, 1996
Results with high-dose chemotherapy and unpurged autologous stem cell transplantation in 73 patients with chronic myelogenous leukemia: the MD Anderson experienceI F Khouri, H M Kantarjian, M Talpaz, et al.
Leukemia|March 1, 1997
Decitabine studies in chronic and acute myelogenous leukemiaH M Kantarjian, S M O'Brien, E Estey, et al.
Cytokines and Molecular Therapy|June 1, 1995
Interferon-alpha and interleukin-2 as treatment for leukemia relapse after allogeneic bone marrow transplantationS Giralt, S O'Brien, M Talpaz, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 8, 1999
Late cytomegalovirus pneumonia in adult allogeneic blood and marrow transplant recipientsQ Nguyen, R Champlin, S Giralt, et al.
Bone Marrow Transplantation|June 7, 2005
Disease burden may identify patients more likely to benefit from second allogeneic hematopoietic stem cell transplantation to treat relapsed acute myelogenous leukemiaC Hosing, R M Saliba, M Shahjahan, et al.
The New England Journal of Medicine|September 9, 1993
Preliminary results of treatment with filgrastim for relapse of leukemia and myelodysplasia after allogeneic bone marrow transplantationS Giralt, S Escudier, H Kantarjian, et al.
Bone Marrow Transplantation|April 1, 2003
Extracorporeal photopheresis therapy in the management of steroid-refractory or steroid-dependent cutaneous chronic graft-versus-host disease after allogeneic stem cell transplantation: feasibility and resultsN Apisarnthanarax, M Donato, M Körbling, et al.
Pageof 18

Showing results (71-80 of 176) with videos related to

Sort By:
Pageof 18
Leukemia|August 26, 2016
Long-term event-free and overall survival after risk-adapted melphalan and SCT for systemic light chain amyloidosisH Landau, M Smith, C Landry, et al.
Bone Marrow Transplantation|September 1, 1994
A phase I-II study of high-dose thiotepa, busulfan and cyclophosphamide as a preparative regimen for allogeneic marrow transplantationD Przepiorka, C Ippoliti, S Giralt, et al.
Bone Marrow Transplantation|April 1, 1994
Ganciclovir three times per week is not adequate to prevent cytomegalovirus reactivation after T cell-depleted marrow transplantationD Przepiorka, C Ippoliti, A Panina, et al.
Bone Marrow Transplantation|May 1, 1996
Results with high-dose chemotherapy and unpurged autologous stem cell transplantation in 73 patients with chronic myelogenous leukemia: the MD Anderson experienceI F Khouri, H M Kantarjian, M Talpaz, et al.
Leukemia|March 1, 1997
Decitabine studies in chronic and acute myelogenous leukemiaH M Kantarjian, S M O'Brien, E Estey, et al.
Cytokines and Molecular Therapy|June 1, 1995
Interferon-alpha and interleukin-2 as treatment for leukemia relapse after allogeneic bone marrow transplantationS Giralt, S O'Brien, M Talpaz, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 8, 1999
Late cytomegalovirus pneumonia in adult allogeneic blood and marrow transplant recipientsQ Nguyen, R Champlin, S Giralt, et al.
Bone Marrow Transplantation|June 7, 2005
Disease burden may identify patients more likely to benefit from second allogeneic hematopoietic stem cell transplantation to treat relapsed acute myelogenous leukemiaC Hosing, R M Saliba, M Shahjahan, et al.
The New England Journal of Medicine|September 9, 1993
Preliminary results of treatment with filgrastim for relapse of leukemia and myelodysplasia after allogeneic bone marrow transplantationS Giralt, S Escudier, H Kantarjian, et al.
Bone Marrow Transplantation|April 1, 2003
Extracorporeal photopheresis therapy in the management of steroid-refractory or steroid-dependent cutaneous chronic graft-versus-host disease after allogeneic stem cell transplantation: feasibility and resultsN Apisarnthanarax, M Donato, M Körbling, et al.
Pageof 18